WeVote
Log In

Bill

Bill

A 5832

Enacts the "PFAS discharge disclosure act"

2025 Regular Session Introduced by George Alvarez and 38 co-sponsors

PFAS discharge disclosure act; A5832 substituted by S4574B. Introduced text instead bars health insurers from cutting provider reimbursements mid-term; final PFAS language pending.

SUBSTITUTED BY S4574B
0
WeVote Research Nonpartisan
Bill Summary · A 5832

Summary — A5832 (Introduced June 16, 2025) — “PFAS discharge disclosure act” (status: substituted by S4574B)

Bill identity & status

  • Bill number: A5832 (Introduced 2025-06-16)
  • Title on cover: “Enacts the ‘PFAS discharge disclosure act’.”
  • Current procedural status: SUBSTITUTED BY S4574B (6/17/2025). Prior referrals/reports include Environmental Conservation, Ways & Means, Rules; reported and ordered to third reading before substitution.
  • Sponsors: Large group of Assembly members (Anna Kelles listed as primary among many cosponsors).

Note: The legislative packet supplied contains a conflict — the printed “Introduced Version” text in the materials is a short health‑insurance provision that differs from the bill’s cover title and committee referrals to Environmental Conservation. Because A5832 was substituted by S4574B, consult S4574B or the final A5832 print for authoritative language.

Text included in the provided “Introduced Version” (actual printed language in packet)

The packet’s introduced language consists of two operative sections:

  1. Carrier contract protection
    • Prohibits a health insurance carrier from making any change to a contract with its network providers that would reduce a provider’s reimbursement during the term of that contract.
  2. Effective date
    • Takes effect on the first day of the third month after enactment and applies to contracts entered into or renewed on or after that effective date.

Practical effect if adopted as written
- Who is affected: health insurance carriers (insurers, HMOs, third‑party administrators with provider networks) and network providers (hospitals, physicians, clinics).
- Impact: prevents carriers from unilaterally reducing payment rates mid‑term; protects providers from retrospective reductions; limits carriers’ ability to adjust reimbursement until contract renewal. The text does not specify enforcement mechanisms, penalties, or carve‑outs (e.g., for contractually permitted adjustments, fraud, or regulatory rate changes).

Title & committee history pointing to PFAS disclosure subject

  • The bill title and committee referrals (Environmental Conservation) indicate the sponsor’s intent was to enact a “PFAS discharge disclosure” law — a statute that, by its name, would require reporting/disclosure of releases of per‑ and polyfluoroalkyl substances (PFAS).
  • However, no PFAS‑specific statutory language is present in the printed Introduced Version included in the packet. A5832 was subsequently substituted by companion bill S4574B on 6/17/2025; that substitute likely contains the controlling language on PFAS if the substitution implemented the sponsor’s intended policy.

Recommendation / next steps for readers

  • Because of the conflicting materials, review the substituted bill S4574B and the latest assembly print (A5832B) to determine the final operative text. That will confirm whether the bill addresses PFAS discharge disclosure (and its requirements) or is limited to the insurance contract provision shown in the packet.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.